A study at Saarland University has shown that a combination with active ingredients from Astrazeneca and Biontech/Pfizer appears to be the best combination.
Apart from a lot of misery, the corona crisis also yields plenty of new insights into the treatment of other diseases.
The vaccine from Pfizer and BioNTech is 90 percent effective. Today, the companies announced the preliminary results of their phase three trials.
The Belgian company Janssen is starting the final phase of their vaccine research in the United States, South Africa and South America. The Netherlands will also have its turn soon.